Proteomic identification of Reticulocalbin 1 as potential tumor marker in renal cell carcinoma

Journal of Proteomics

Volumn 91, Issue , 2013, Pages 385-392

  Giribaldi, Giuliana ^a   Barbero, Giovanna ^a   Mandili, Giorgia ^a   Daniele, Lorenzo ^a   Khadjavi, Amina ^a   Notarpietro, Agata ^a   Ulliers, Daniela ^a   Prato, Mauro ^a   Minero, Valerio G ^a   Battaglia, Antonino ^b   Allasia, Marco ^b   Bosio, Andrea ^b   Sapino, Anna ^a   Gontero, Paolo ^b   Frea, Bruno ^b   Fontana, Dario ^b   Destefanis, Paolo ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

Author keywords

Immunohistochemistry; Proteomics; Renal cancer; Reticulocalbin 1; Tumor markers

Indexed keywords

RETICULOCALBIN 1; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NEPHRECTOMY; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

3,3′-DIAMINOBENZIDINE; DAB; IHC; IMMUNOHISTOCHEMISTRY; PROTEOMICS; RCC; RCN1; RENAL CANCER; RENAL CELL CARCINOMA; RETICULOCALBIN 1; TUMOR MARKERS; WB; WESTERN BLOTTING;

ADULT; AGED; CALCIUM-BINDING PROTEINS; CARCINOMA, RENAL CELL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEPHRECTOMY; PROGNOSIS; PROTEOMICS; TUMOR MARKERS, BIOLOGICAL;

EID: 84883227079     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2013.07.018     Document Type: Article

References (29)

1. Vera-Badillo F.E., Conde E., Duran I. Chromophobe renal cell carcinoma: a review of an uncommon entity. Int J Urol 2012, 19:894-900.
2. Chow W.H., Dong L.M., Devesa S.S. Epidemiology and risk factors for kidney cancer. Nat Rev Urol 2010, 7:245-257.
3. Kane C.J., Mallin K., Ritchey J., Cooperberg M.R., Carroll P.R. Renal cell cancer stage migration: analysis of the National Cancer Data Base. Cancer 2008, 113:78-83.
4. Bukowski R.M. Biomarkers in renal cell carcinoma: what next?. Curr Oncol Rep 2011, 13:87-89.
5. Bukowski R.M. Prognostic factors for survival in metastatic renal cell carcinoma: update. 2008. Cancer 2009, 115:2273-2281.
6. Shah J.B., Margulis V. In search of a better crystal ball: recent advances in prognostic markers for clear-cell renal cell carcinoma. Expert Rev Anticancer Ther 2010, 10:837-842.
7. Cairns P. Renal cell carcinoma. Cancer Biomark 2010, 9:461-473.
8. Shen S.S., Truong L.D., Scarpelli M., Lopez-Beltran A. Role of immunohistochemistry in diagnosing renal neoplasms: when is it really useful?. Arch Pathol Lab Med 2012, 136:410-417.
9. Netto G.J., Cheng L. Emerging critical role of molecular testing in diagnostic genitourinary pathology. Arch Pathol Lab Med 2012, 136:372-390.
10. Sandim V., Pereira D.A., Ornellas A.A., Alves G. Renal cell carcinoma and proteomics. Urol Int 2010, 84:373-377.
11. Okamura N., Masuda T., Gotoh A., Shirakawa T., Terao S., Kaneko N., et al. Quantitative proteomic analysis to discover potential diagnostic markers and therapeutic targets in human renal cell carcinoma. Proteomics 2008, 8:3194-3203.
12. Barbero G., Carta F., Giribaldi G., Mandili G., Crobu S., Ceruti C., et al. Protein/RNA coextraction and small two-dimensional polyacrylamide gel electrophoresis for proteomic/gene expression analysis of renal cancer biopsies. Anal Biochem 2006, 349:62-71.
13. Mandili G., Marini C., Carta F., Zanini C., Prato M., Khadjavi A., et al. Identification of phosphoproteins as possible differentiation markers in all-trans-retinoic acid-treated neuroblastoma cells. PLoS One 2011, 6:e18254.
14. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
15. Cooper C.R., Graves B., Pruitt F., Chaib H., Lynch J.E., Cox A.K., et al. Novel surface expression of reticulocalbin 1 on bone endothelial cells and human prostate cancer cells is regulated by TNF-alpha. J Cell Biochem 2008, 104:2298-2309.
16. Junker H., Venz S., Zimmermann U., Thiele A., Scharf C., Walther R. Stage-related alterations in renal cell carcinoma-comprehensive quantitative analysis by 2D-DIGE and protein network analysis. PLoS One 2011, 6:e21867.
17. Valera V.A., Li-Ning-T E., Walter B.A., Roberts D.D., Linehan W.M., Merino M.J. Protein expression profiling in the spectrum of renal cell carcinomas. J Cancer 2010, 1:184-196.
18. Seliger B., Dressler S.P., Wang E., Kellner R., Recktenwald C.V., Lottspeich F., et al. Combined analysis of transcriptome and proteome data as a tool for the identification of candidate biomarkers in renal cell carcinoma. Proteomics 2009, 9:1567-1581.
19. Siu K.W., DeSouza L.V., Scorilas A., Romaschin A.D., Honey R.J., Stewart R., et al. Differential protein expressions in renal cell carcinoma: new biomarker discovery by mass spectrometry. J Proteome Res 2009, 8:3797-3807.
20. Christou G.A., Tselepis A.D., Kiortsis D.N. The metabolic role of retinol binding protein 4: an update. Horm Metab Res 2012, 44:6-14.
21. Ozawa M., Muramatsu T. Reticulocalbin, a novel endoplasmic reticulum resident Ca(2+)-binding protein with multiple EF-hand motifs and a carboxyl-terminal HDEL sequence. J Biol Chem 1993, 268:699-705.
22. Honoré B., Vorum H. The CREC family, a novel family of multiple EF-hand, low-affinity Ca(2+)-binding proteins localised to the secretory pathway of mammalian cells. FEBS Lett 2000, 466:11-18.
23. Honoré B. The rapidly expanding CREC protein family: members, localization, function, and role in disease. Bioessays 2009, 31:262-277.
24. Kent J., Lee M., Schedl A., Boyle S., Fantes J., Powell M., et al. The Reticulocalbin gene maps to the WAGR region in human and to the Small eye Harwell deletion in mouse. Genomics 1997, 42:260-267.
25. Fukuda T., Oyamada H., Isshiki T., Maeda M., Kusakabe T., Hozumi A., et al. Distribution and variable expression of secretory pathway protein reticulocalbin in normal human organs and non-neoplastic pathological conditions. J Histochem Cytochem 2007, 55:335-345.
26. Liu Z., Brattain M.G., Appert H. Differential display of reticulocalbin in the highly invasive cell line, MDA-MB-435, versus the poorly invasive cell line, MCF-7. Biochem Biophys Res Commun 1997, 231:283-289.
27. Nimmrich I., Erdmann S., Melchers U., Finke U., Hentsch S., Moyer M.P., et al. Seven genes that are differentially transcribed in colorectal tumor cell lines. Cancer Lett 2000, 160:37-43.
28. Yu L.R., Zeng R., Shao X.X., Wang N., Xu Y.H., Xia Q.C. Identification of differentially expressed proteins between human hepatoma and normal liver cell lines by two-dimensional electrophoresis and liquid chromatography-ion trap mass spectrometry. Electrophoresis 2000, 21:3058-3068.
29. Hirano T., Kato H., Maeda M., Gong Y., Shou Y., Nakamura M., et al. l. Identification of postoperative adjuvant chemotherapy responders in non-small cell lung cancer by novel biomarker. Int J Cancer 2005, 117:460-468.